Discriminating WM from chronic lymphocytic leukemia (CLL), mantle cell lymphoma (MCL), and follicular lymphoma involves noting the presence of CD19, CD20, CD22, CD79α, and CD138 cell expression and lack of CD5, CD10, and CD23. Here, FCER2 is linked to mantle cell lymphoma.